Nimbus Discovery Garners New Financing Round

  • Feed Type
  • Date
  • Company Name
    Nimbus Discovery
  • Mailing Address
    25 1st St. Cambridge, MA 02141
  • Company Description
    Nimbus Discovery is applying advances in computer-based drug discovery to unlock fundamental biological pathways. Nimbus has already delivered selective, potent, and differentiated compounds within the first year for two disease targets, IRAK4 and ACC, which are pivotal to the progression of an aggressive subtype of non-Hodgkin’s lymphoma and obesity, respectively.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The funds will be used to advance Nimbus’ lead programs in diffuse large B-cell lymphoma, an aggressive blood cancer, inflammatory disorders, and metabolic disease.
  • M&A Terms
  • Venture Investor
    Cascade Investment
  • Venture Investor
    Atlas Venture

Trending on Xconomy